The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smeltz, R. B.
Right arrow Articles by Swanborg, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smeltz, R. B.
Right arrow Articles by Swanborg, R. H.
The Journal of Immunology, 1999, 162: 829-836.
Copyright © 1999 by The American Association of Immunologists

Critical Requirement for Aspartic Acid at Position 82 of Myelin Basic Protein 73–86 for Recruitment of Vß8.2+ T Cells and Encephalitogenicity in the Lewis Rat

Ronald B. Smeltz*, Marca H. M. Wauben{dagger}, Norbert A. Wolf* and Robert H. Swanborg*

* Departments of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, MI 48201; and {dagger} Institute of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands

We synthesized single amino acid-substituted peptide analogues of guinea pig myelin basic protein (MBP) 73–86 to study the importance of aspartic acid at residue 82 (QKSQRSQDENPV), which previous reports have suggested is a critical TCR contact residue. Whereas the wild-type 73–86 peptide elicited severe experimental autoimmune encephalomyelitis (EAE) in the Lewis rat, none of the peptide analogues with substitutions at position 82 were capable of inducing EAE. The inability to cause EAE was not due to a failure to bind MHC or to elicit T cell proliferation and cytokine secretion. T cells specific for MBP73–86 did not cross-react with any of the analogues tested, further indicating the importance of this residue in T cell responses to 73–86. Analysis by flow cytometry showed that only the wild-type 73–86 peptide was capable of recruiting Vß8.2+ T cells, which have been shown previously to be important for disease induction. Reduced expression of the Vß8.2 TCR was also seen in Lewis rats protected from EAE by coimmunization of MBP73–86 with 73–86(82D->A), despite an increase in cytokine production when both peptides were present during in vitro culture. The data indicate that aspartic acid 82 is a critical TCR contact residue and is required for the recruitment of Vß8.2+ T cells and the encephalitogenic activity of MBP73–86.




This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Galazka, A. Jurewicz, W. Orlowski, M. Stasiolek, C. F. Brosnan, C. S. Raine, and K. Selmaj
EAE Tolerance Induction with Hsp70-Peptide Complexes Depends on H60 and NKG2D Activity
J. Immunol., October 1, 2007; 179(7): 4503 - 4512.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
F. C. Westall
Molecular mimicry revisited: gut bacteria and multiple sclerosis.
J. Clin. Microbiol., June 1, 2006; 44(6): 2099 - 2104.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. C. Lenz, L. Lu, S. B. Conant, N. A. Wolf, H. C. Gerard, J. A. Whittum-Hudson, A. P. Hudson, and R. H. Swanborg
A Chlamydia pneumoniae-Specific Peptide Induces Experimental Autoimmune Encephalomyelitis in Rats
J. Immunol., August 1, 2001; 167(3): 1803 - 1808.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. B. Smeltz, N. A. Wolf, and R. H. Swanborg
Inhibition of Autoimmune T Cell Responses in the DA Rat by Bone Marrow-Derived NK Cells In Vitro: Implications for Autoimmunity
J. Immunol., August 1, 1999; 163(3): 1390 - 1397.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.